PHOENIX (AZFamily) — A favorite family-owned Valley pizzeria is revamping its menu while still keeping the classics, adding new items that accommodate all guests’ dietary needs. Spinato’s Pizzeria & ...

NORTH BETHESDA, Md., Feb. 03, 2026 (GLOBE NEWSWIRE) -- As aerospace and defense (A&D) programs accelerate and production demands increase, organizations across the defense industrial base are ...

If you’ve ever looked at the options chain, you probably noticed how complicated it seems. These numbers and letters make options look more like an algebra class than a financial product. However, ...

(OSV News) — In a nation fixated on affordability, a Catholic school K-12 education can easily become a contested line in the family budget. But as the experts who spoke with OSV News underscored, ...

According to Greg Brockman on Twitter, Codex is now demonstrating significant improvements in identifying security vulnerabilities within code. OpenAI is exploring trusted access programs specifically ...

SOLON, Ohio -- Solon High School juniors took an early step toward life after graduation this month through the school’s annual Junior Jump Start program. The program introduces students to college ...

Subway’s new loyalty program isn’t going over well with a key constituent: The franchisees. The “Sub Club” program, a modernized version of the chain’s old Sub Club stamp-collecting loyalty program ...

Abstract: The frequency of supply-chain attacks has reached unprecedented levels, amounting to a growing concern about the security of open-source software. Existing state-of-the-art techniques often ...

If you follow the restaurant industry even casually, you have probably noticed that a lot of restaurants seem to be changing up their loyalty programs recently. Over the past two years, a long list of ...

BioWorld - Monday, November 17, 2025 Breaking News: Trump administration impacts continue to roil the life sciences sector See today's BioWorld Science Home » Prelude signs option deal, prioritizes ...

Incyte (INCY) has signed an agreement with Prelude Therapeutics (PRLD) for an exclusive option license for Prelude's mutant selective JAK2V617F JH2 inhibitor program to treat a type of rare blood ...